Swine respiratory diseases are diseases are prevalent cause for nursery pig deaths, according to a survey in 1996, by National Animal Health Monitoring System. In some cases, the infection is caused by single pathogen, in few cases two or multiple infectious agents are involved. Few prominent pathogens responsible for causing swine respiratory diseases include Actinobacillus Pleuropneumoniae (APP), Mycoplasma Hyopneumoniae, Bordetella Bronchiseptica, while some viral agents causing swine respiratory diseases are Swine Influenza Virus (SIV), Porcine Reproductive and Respiratory Syndrome (PRRS) Virus. Some secondary agents causing swine respiratory diseases are Streptococcus suis, Pasteurella multocida, Haemophilus parasuis, Salmonella choleraesuis, and Actinobacillus suis. The duration and severity of the disease is increased when the infectious agents act together. For diagnosis of swine respiratory diseases, it’s necessary to identify the causing agents involved, so that effective treatment and prevention can be implemented. While for treatment there are various treatment options are available for swine respiratory disease treatment, it’s necessary to control environmental factors such as frequent mixing of pigs, overcrowding, dust, high humidity, temperature fluctuations and high ammonia levels. Minimizing such factors can reduce infections and help to improve swine health as well. Delaying in treatment or lack of proper treatment of swine respiratory diseases can hamper economically as well, it can lead to increased days to market, sort loss, high mortality rate, higher cull rate, lower feed efficiency and high treatment costs.
The global swine respiratory diseases treatment market is driven by increased respiratory infections in pigs. Lack of proper diagnosis of specific disease can lead to spreading of infection amongst the animals, fueling global swine respiratory diseases treatment market. Lack of vaccination is another driving factor in global swine respiratory diseases treatment market.
However, the high cost of swine respiratory diseases treatment, and unawareness about advanced technologies in Swine Respiratory Diseases Treatment can impact negatively on the revenue growth of the swine respiratory disease treatment market and restrain the growth of the global market over the forecast period.
Swine Respiratory Diseases Treatment market has been segmented on the basis of treatment type, indication, route of administration, distribution channel, and region
Swine Respiratory Diseases Treatment Market Segmented By Treatment Type – Treatment Medicines, (Deftiofur crystalline free acid, Tulathromycin, Lincomycin, Others), Preventive Vaccines, Others; By Indication – Mycoplasmal (Enzootic) Pneumonia, Swine Influenza, Classical Swine Fever, Porcine Reproductive and Respiratory Syndrome (PRRS), Pseudorabies, Porcine Circovirus-Associated Disease, Others; By Route Of Administration – Oral, Parenteral, Other; By Distribution Channel – Veterinary Pharmacies
Players in swine respiratory diseases treatment market are adopting reduced use of antibiotics and new product innovation as the key strategy. Owing to high revenue in the swine respiratory diseases treatment market, players are investing to strengthen their portfolios. By indication type, preventive vaccines are anticipated to grow in positive traction owing to global rising awareness for swine respiratory diseases preventive majors.
Geographically, Swine Respiratory Diseases Treatment market is segmented into regions viz. North America, Latin America, Europe, Asia Pacific and Japan, Middle East and Africa. North America and Europe regions are anticipated to garner larger market revenue share in swine respiratory diseases treatment market over the forecast period owing to increasing number of pig farming in the region. Awareness of Swine Respiratory Diseases Treatment is anticipated to fuel the revenue growth in the region. The countries like India and China are attractive markets for key players for global Swine Respiratory Diseases Treatment market.
The key players in percutaneous screw placement system market include Zoetis Services LLC., Virbac group, Eli Lilly Company, to name a few.